111 Westminster Bridge Road
SE1 7HR London
Phone: +44 20 7960-4382
The Association of British Healthcare Industries (ABHI) is the lead industry association for the medical technology sector. This sector comprises not only manufacturers of medical devices, equipment and consumables, but also service companies, distributors, professional groups (such as architects and lawyers), and other suppliers to the medical community.
ABHI has around 200 member companies whose annual output is about 80% of the industry’s total. The membership currently includes eleven Special Interest Sections, four sectoral trade associations. We also have numerous working groups, policy groups and committees.
What we do:
Driving the health and wealth of the UK
For members, the ABHI ensures that the best and most appropriate medical technologies are made available to patients and clinicians in support of life-long health and facilitates the development of a vibrant market environment that supports and rewards innovation.
Keeping members informed about the evolving market
The ABHI provides informed business intelligence that keeps members up-to-date on the constant and complex changes in the UK market.
Shaping the business environment
The ABHI is the first port of call for decision-makers when seeking the opinion of industry on critical issues affecting the UK.
ABHI environment-shaping activities include ensuring regulation and legislation remains sensible and intelligent and that the sector is accurately represented in the media.
Members can be represented directly or indirectly to key government agencies, parliamentarians, healthcare professionals, patient groups, and other key stakeholders, as a result of the ABHI’s strong and long-standing working relationships.
Providing powerful networking opportunities
The ABHI provides a legitimate forum for members to network with stakeholders, peers and customers, through special interest groups, meetings, exhibitions and conferences.
Ensuring innovation translates into business success
The ABHI works to improve the R&D climate by aligning government funding, improving the environment for conducting clinical evaluation and enhancing collaborative activity in order that the sector can convert innovation into business.